Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-02-01

Clinical Trial Update: Dexamethasone Dyspnea Study [Phase 2]

View source ↗

Summary

Phase 2 trial update for dexamethasone addressing dyspnea in advanced cancers and hematologic disorders; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DEXAMETHASONE (Dexamethasone)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Advanced Cancers, Hematologic Disorder | Phase 2 | Status: COMPLETED | Results posted: 2021-02-01